EZH2-IN-11

• UNSPSC Description:

  EZH2-IN-11 is a potent inhibitor of E2HZ. The oncogenic activities of EZH2 have been shown by a number of studies in various different cancer types. EZH2-IN-11 has the potential for the research of cancer diseases (extracted from patent WO2019204490A1, compound 17)[1].

• Target Antigen:

  Histone Methyltransferase

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ezh2-in-11.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC(Cl)=C(OC(C)(C2CCC(N3CC(OC)C3)CC2)O4)C4=C1C)NCC5=C(SC)C=C(C)NC5=O

• Molecular Weight:

  562.12

• References & Citations:

  [1]Alexandre Côté, et al. Modulators of methyl modifying enzymes, compositions and uses thereof. Patent WO2019204490A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2387402-80-2